Congress

Politics Rachel Cohrs Zhang

STAT Plus: Second House panel advances two-year telehealth extension

D.C. Diagnosis Rachel Cohrs Zhang

WuXi Biologics beefs up its lobbying operation

The Readout Elaine Chen

STAT Plus: Blackstone wants in on red-hot immunology market

Politics John Wilkerson

STAT Plus: WuXi Biologics execs register to lobby as Congress comes for the company

Politics Sarah Owermohle

STAT Plus: HHS suspends federal funding for EcoHealth Alliance

Pharmalot Ed Silverman

STAT Plus: Lawmaker accuses Amgen of placing profits above patients with dosing for a cancer drug

First Opinion Brian Hurley and Paul N. Samuels

Congress: Close Medicare’s dangerous gaps in coverage for addiction treatment

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: CDC goes hard on military pets

Politics John Wilkerson

STAT Plus: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

Health tech Mario Aguilar and Rachel Cohrs Zhang

STAT Plus: House panel eyes PBM reform to pay for telehealth extensions

Politics Mario Aguilar and Rachel Cohrs Zhang

STAT Plus: Lawmakers unlikely to permanently extend telehealth flexibilities this year

Politics Sarah Owermohle

STAT Plus: Republicans, concerned about dairy industry, urge calm about H5N1 bird flu

D.C. Diagnosis Rachel Cohrs Zhang

UnitedHealth’s Andrew Witty gets no pity in Congress

First Opinion Martha Gershun and Rosa DeLauro

The U.S. needs a reliable supply of baby formula. A new bill in Congress can help

Politics Sarah Owermohle

Lawmakers, as part of ‘lab leak’ Covid inquiry, press to bar EcoHealth from federal research funds

The Readout Elaine Chen

STAT Plus: FDA wants to hear your thoughts on advisory committees 

Politics John Wilkerson

STAT Plus: Momentum builds for House bill cracking down on Chinese biotechs

First Opinion Alex Azar and Kathleen G. Sebelius

Former HHS secretaries: Congress should adopt site-neutral payments for health care

Politics John Wilkerson

STAT Plus: How BIO CEO’s cozy relationship with WuXi soured

First Opinion Molly O'Shea

Kids can’t wait any longer for social media safety

Politics Rachel Cohrs Zhang

STAT Plus: Chuck Schumer’s broken promise on affordable insulin

Politics Nicholas Florko

STAT Plus: Grocers are pushing legislation they claim would enhance food safety. Advocates say it would gut FDA rules

The Readout Meghana Keshavan

STAT Plus: Lawmakers want to add more Chinese biotechs to defense list

Health Care Inc. Tara Bannow

Why a bill meant to stop surprise medical bills hasn’t worked

The Readout Damian Garde

STAT Plus: What’s Congress going to do with WuXi?

Politics John Wilkerson

STAT Plus: Medicare expected to negotiate obesity drug prices soon, new analysis predicts

Politics John Wilkerson

STAT Plus: BIO severs ties with WuXi in the face of U.S. government concerns over China

The Readout Damian Garde

STAT Plus: Geron’s resurgence might have been short-lived

First Opinion Benjamin Chartock

STAT Plus: Good health care price transparency rules are at risk if Congress doesn’t act